Find Nedocromilo manufacturers, exporters & distributors on PharmaCompass

Nedocromilo

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 69049-73-6, Fpl 59002, 9-ethyl-4,6-dioxo-10-propyl-6,9-dihydro-4h-pyrano[3,2-g]quinoline-2,8-dicarboxylic acid, Nedocromilo, Nedocromilum, Fpl-59002

Molecular Formula

C₁₉H₁₇NO₇

Molecular Weight

371.3 g/mol

InChI Key

RQTOOFIXOKYGAN-UHFFFAOYSA-N

FDA UNII

0B535E0BN0

A pyranoquinolone derivative that inhibits activation of inflammatory cells which are associated with ASTHMA, including EOSINOPHILS; NEUTROPHILS; MACROPHAGES; MAST CELLS; MONOCYTES; AND PLATELETS.

Nedocromil is a Mast Cell Stabilizer. The physiologic effect of nedocromil is by means of Decreased Histamine Release.

1 2D Structure

Nedocromilo

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

9-ethyl-4,6-dioxo-10-propylpyrano[3,2-g]quinoline-2,8-dicarboxylic acid

2.1.2 InChI

InChI=1S/C19H17NO7/c1-3-5-9-16-10(13(21)7-12(18(23)24)20(16)4-2)6-11-14(22)8-15(19(25)26)27-17(9)11/h6-8H,3-5H2,1-2H3,(H,23,24)(H,25,26)

2.1.3 InChI Key

RQTOOFIXOKYGAN-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CCCC1=C2C(=CC3=C1OC(=CC3=O)C(=O)O)C(=O)C=C(N2CC)C(=O)O

2.2 Other Identifiers

2.2.1 UNII

0B535E0BN0

2.3 Synonyms

2.3.1 MeSH Synonyms

1. 9-ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4h-pyrano(3,2-g)quinoline-2,8-dicarboxylic Acid

2. Alocril

3. Brionil

4. Calcium, Nedocromil

5. Cetimil

6. Fpl 59002

7. Fpl-59002

8. Fpl59002

9. Halamid

10. Irtan

11. Nedocromil Calcium

12. Nedocromil Sodium

13. Nedocromil, Calcium Salt (1:1)

14. Nedocromil, Disodium Salt

15. Nedocromil, Disodium Salt, Hydrate

16. Rapitil

17. Sodium, Nedocromil

18. Tilad

19. Tilade

20. Tilaire

21. Tilavist

2.3.2 Depositor-Supplied Synonyms

1. 69049-73-6

2. Fpl 59002

3. 9-ethyl-4,6-dioxo-10-propyl-6,9-dihydro-4h-pyrano[3,2-g]quinoline-2,8-dicarboxylic Acid

4. Nedocromilo

5. Nedocromilum

6. Fpl-59002

7. 9-ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4h-pyrano(3,2-g)quinoline-2,8-dicarboxylic Acid

8. Chebi:7492

9. 0b535e0bn0

10. 9-ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4h-pyrano(3,2-g)chinolin-2,8-dicarbonsaeure

11. Ncgc00182073-02

12. Nedocromilum [latin]

13. Nedocromilo [spanish]

14. Dsstox_cid_3356

15. 9-ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4h-pyrano[3,2-g]quinoline-2,8-dicarboxylic Acid

16. Dsstox_rid_76990

17. Dsstox_gsid_23356

18. Cas-69049-73-6

19. Nedocromil [usan:inn:ban]

20. Unii-0b535e0bn0

21. Fpl59002

22. Nedocromil [mi]

23. Nedocromil [inn]

24. Nedocromil (usan/inn)

25. Nedocromil [usan]

26. Nedocromil [vandf]

27. Chembl746

28. Schembl4611

29. 4h-pyrano(3,2-g)quinoline-2,8-dicarboxylic Acid, 9-ethyl-6,9-dihydro-4,6-dioxo-10-propyl-

30. Nedocromil [who-dd]

31. Bidd:gt0716

32. Gtpl7607

33. Dtxsid7023356

34. Nedocromil, >=98% (hplc)

35. Ex-a098

36. Bcp22724

37. Zinc3782807

38. Tox21_113148

39. Mfcd00864606

40. 9-ethyl-4,6-dioxo-10-propylpyrano[3,2-g]quinoline-2,8-dicarboxylic Acid

41. Akos016014051

42. Tox21_113148_1

43. Db00716

44. Ncgc00182073-03

45. Ncgc00182073-07

46. Ac-30178

47. As-56153

48. Hy-13448

49. Db-055217

50. Ft-0630782

51. C07255

52. D05129

53. 049n736

54. L001326

55. Q416706

56. Sr-01000944506

57. Sr-01000944506-1

58. 9-ethyl-4,6-dioxo-10-propylpyrano[5,6-g]quinoline-2,8-dicarboxylic Acid

59. 9-ethyl-4,6-dioxo-10-propyl-4h,6h,9h-chromeno[7,6-b]pyridine-2,8-dicarboxylic Acid

2.4 Create Date

2005-06-24

3 Chemical and Physical Properties

Molecular Formula	C₁₉H₁₇NO₇
Molecular Weight	371.3 g/mol
XLogP3	2.2
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	8
Rotatable Bond Count	5
Exact Mass	371.10050188 g/mol
Monoisotopic Mass	371.10050188 g/mol
Topological Polar Surface Area	121 Å²
Heavy Atom Count	27
Formal Charge	0
Complexity	753
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

4 Drug and Medication Information

4.1 Drug Information

1 of 1
Drug Name	Alocril
PubMed Health	Nedocromil
Drug Classes	Antiasthma, Mast Cell Stabilizer, Ophthalmologic Agent
Active Ingredient	Nedocromil sodium
Dosage Form	Solution/drops
Route	Ophthalmic
Strength	2%
Market Status	Prescription
Company	Allergan

4.2 Drug Indication

For the treatment of mild to moderate asthma

FDA Label

5 Pharmacology and Biochemistry

5.1 Pharmacology

Nedocromil is a anti-inflammatory agent and can be administered directly to the bronchial mucosa. It has significant inhibitory effect on allergen-induced early and late asthmatic reactions and on bronchial hyperresponsiveness.

5.2 MeSH Pharmacological Classification

Anti-Asthmatic Agents

Drugs that are used to treat asthma. (See all compounds classified as Anti-Asthmatic Agents.)

Mast Cell Stabilizers

Compounds that prevent the release of inflammatory mediators from MAST CELLS. (See all compounds classified as Mast Cell Stabilizers.)

Anti-Allergic Agents

Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)

Anti-Inflammatory Agents

Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)

5.3 FDA Pharmacological Classification

5.3.1 Active Moiety

NEDOCROMIL

5.3.2 FDA UNII

0B535E0BN0

5.3.3 Pharmacological Classes

Established Pharmacologic Class [EPC] - Mast Cell Stabilizer

5.4 ATC Code

R - Respiratory system

R01 - Nasal preparations

R01A - Decongestants and other nasal preparations for topical use

R01AC - Antiallergic agents, excl. corticosteroids

R01AC07 - Nedocromil

R - Respiratory system

R03 - Drugs for obstructive airway diseases

R03B - Other drugs for obstructive airway diseases, inhalants

R03BC - Antiallergic agents, excl. corticosteroids

R03BC03 - Nedocromil

S - Sensory organs

S01 - Ophthalmologicals

S01G - Decongestants and antiallergics

S01GX - Other antiallergics

S01GX04 - Nedocromil

5.5 Absorption, Distribution and Excretion

Absorption

Low

Route of Elimination

It is not metabolized and is eliminated primarily unchanged in urine (70%) and feces (30%).

5.6 Metabolism/Metabolites

Nedocromil is not metabolized after IV administration and is excreted unchanged.

5.7 Biological Half-Life

~3.3 hours

5.8 Mechanism of Action

Nedocromil has been shown to inhibit the in vitro activation of, and mediator release from, a variety of inflammatory cell types associated with asthma, including eosinophils, neutrophils, macrophages, mast cells, monocytes, and platelets. Nedocromil inhibits activation and release of inflammatory mediators such as histamine, prostaglandin D2 and leukotrienes c4 from different types of cells in the lumen and mucosa of the bronchial tree. These mediators are derived from arachidonic acid metabolism through the lipoxygenase and cyclo-oxygenase pathways. The mechanism of action of nedocromil may be due partly to inhibition of axon reflexes and release of sensory neuropeptides, such as substance P, neurokinin A, and calcitonin-geneñrelated peptides. The result is inhibition of bradykinin-induced bronchoconstriction. Nedocromil does not posess any bronchodilator, antihistamine, or corticosteroid activity.

ABOUT THIS PAGE

Nedocromilo Manufacturers

A Nedocromilo manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Nedocromilo, including repackagers and relabelers. The FDA regulates Nedocromilo manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Nedocromilo API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

Nedocromilo Suppliers

A Nedocromilo supplier is an individual or a company that provides Nedocromilo active pharmaceutical ingredient (API) or Nedocromilo finished formulations upon request. The Nedocromilo suppliers may include Nedocromilo API manufacturers, exporters, distributors and traders.

Nedocromilo GMP

Nedocromilo Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Nedocromilo GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Nedocromilo GMP manufacturer or Nedocromilo GMP API supplier for your needs.

Nedocromilo CoA

A Nedocromilo CoA (Certificate of Analysis) is a formal document that attests to Nedocromilo's compliance with Nedocromilo specifications and serves as a tool for batch-level quality control.

Nedocromilo CoA mostly includes findings from lab analyses of a specific batch. For each Nedocromilo CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Nedocromilo may be tested according to a variety of international standards, such as European Pharmacopoeia (Nedocromilo EP), Nedocromilo JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Nedocromilo USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.